We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-0.48%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$145M
AUM Growth
-$36.8M
Cap. Flow
-$35M
Cap. Flow %
-24.08%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

1
DYN icon
Dyne Therapeutics
DYN
+$35M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRDA icon
1
Entrada Therapeutics
TRDA
$267M
$70.7M 48.68%
4,425,784
ITOS
2
DELISTED
iTeos Therapeutics
ITOS
$28M 19.25%
2,738,785
DYN icon
3
Dyne Therapeutics
DYN
$3.76B
$24.5M 16.87%
682,376
-879,120
-56% -$35M
HOWL icon
4
Werewolf Therapeutics
HOWL
$17.9M
$9.08M 6.25%
4,284,172
RPTX
5
DELISTED
Repare Therapeutics
RPTX
$7.71M 5.31%
2,242,636
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$5.28M 3.63%
5,555,461

Similar funds

MPM Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, MPM Asset Management held 6 positions worth $145M, down 20% from $182M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management withdrew a net $35M in Q3 2024, reducing 1 holding. Its largest reduction was Dyne Therapeutics, cutting an estimated $35M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q3 2024 reduction was Dyne Therapeutics, cutting an estimated $35M.
  • MPM Asset Management's ten largest holdings make up 100% of its $145M portfolio in Q3 2024.
  • MPM Asset Management opened 0 new positions and closed 0 in Q3 2024.
  • MPM Asset Management's portfolio value fell 20% quarter-over-quarter to $145M.

Based on MPM Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.